C000021062 Holdings — VIP Health Care Portfolio
All 133 reported holdings of VIP Health Care Portfolio (C000021062) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Danaher Corp. | 6.80% | $68.26M |
| ELI LILLY and CO | 6.67% | $66.96M |
| JOHNSON and JOHNSON | 5.91% | $59.35M |
| Boston Scientific Corp. | 5.06% | $50.83M |
| Abbvie, Inc. | 3.62% | $36.32M |
| Gilead Sciences, Inc. | 2.58% | $25.92M |
| Ucb SA | 2.55% | $25.61M |
| MERCK and CO INC | 2.52% | $25.26M |
| Ascendis Pharma A/s | 2.50% | $25.16M |
| Edwards Lifesciences Corp. | 2.07% | $20.82M |
| Fidelity Revere Street Trust | 2.00% | $20.09M |
| Alnylam Pharmaceuticals, Inc. | 1.98% | $19.85M |
| Argenx SE | 1.95% | $19.57M |
| Thermo Fisher Scientific, Inc. | 1.80% | $18.09M |
| Insmed, Inc. | 1.60% | $16.02M |
| Cencora, Inc. | 1.56% | $15.71M |
| Cogent Biosciences, Inc. | 1.53% | $15.40M |
| Brightspring Health Services, Inc. | 1.48% | $14.91M |
| Nuvalent, Inc. | 1.31% | $13.11M |
| Mckesson Corp. | 1.29% | $12.98M |
| Unitedhealth Group, Inc. | 1.25% | $12.58M |
| Moderna, Inc. | 1.24% | $12.45M |
| Xenon Pharmaceuticals, Inc. | 1.20% | $12.10M |
| Cvs Health Corp. | 1.14% | $11.49M |
| Centessa Pharmaceuticals PLC | 1.13% | $11.32M |
| Caris Life Sciences, Inc. | 1.05% | $10.55M |
| Vaxcyte, Inc. | 1.04% | $10.46M |
| Royalty Pharma PLC | 1.03% | $10.31M |
| Viridian Therapeutics, Inc. | 1.00% | $10.07M |
| Fidelity Revere Street Trust | 0.99% | $9.94M |
| Medline, Inc. | 0.97% | $9.70M |
| Roche Holding AG | 0.95% | $9.58M |
| Repligen Corp. | 0.91% | $9.19M |
| Insulet Corp. | 0.91% | $9.13M |
| Veeva Sys, Inc. | 0.87% | $8.78M |
| Enliven Therapeutics, Inc. | 0.85% | $8.55M |
| Waystar Holding Corp. | 0.85% | $8.53M |
| Spyre Therapeutics, Inc. | 0.84% | $8.47M |
| Legend Biotech Corp. | 0.83% | $8.32M |
| Privia Health Group, Inc. | 0.82% | $8.23M |
| Oruka Therapeutics, Inc. | 0.79% | $7.95M |
| Crinetics Pharmaceuticals, Inc. | 0.79% | $7.92M |
| Veracyte, Inc. | 0.77% | $7.73M |
| Bio Techne Corp. | 0.73% | $7.32M |
| Disc Medicine, Inc. | 0.73% | $7.29M |
| Kiniksa Pharmaceuticals International PLC | 0.72% | $7.22M |
| Intuitive Surgical, Inc. | 0.71% | $7.15M |
| Cg Oncology, Inc. | 0.71% | $7.11M |
| Praxis Precision Medicines Inc. | 0.70% | $7.02M |
| 10x Genomics, Inc. | 0.69% | $6.96M |
| Cytokinetics, Inc. | 0.66% | $6.59M |
| Alignment Healthcare, Inc. | 0.63% | $6.34M |
| Kymera Therapeutics, Inc. | 0.63% | $6.33M |
| Roivant Sciences Ltd. | 0.63% | $6.32M |
| West Pharmaceutical Svcs, Inc. | 0.62% | $6.27M |
| Axsome Therapeutics, Inc. | 0.59% | $5.92M |
| Lifestance Health Group, Inc. | 0.55% | $5.48M |
| Stryker Corp. | 0.51% | $5.13M |
| Structure Therapeutics, Inc. | 0.51% | $5.11M |
| Sartorius Stedim Biotech | 0.48% | $4.87M |
| Mineralys Therapeutics, Inc. | 0.47% | $4.74M |
| Heartflow, Inc. | 0.47% | $4.72M |
| Beone Medicines Ltd. | 0.44% | $4.45M |
| Cigna Group (the) | 0.44% | $4.40M |
| Guardant Health, Inc. | 0.41% | $4.16M |
| Cytomx Therapeutics, Inc. | 0.40% | $4.04M |
| Olema Pharmaceuticals, Inc. | 0.39% | $3.95M |
| Stoke Therapeutics, Inc. | 0.39% | $3.91M |
| Newamsterdam Pharma Company NV | 0.37% | $3.68M |
| Zenas Biopharma, Inc. | 0.36% | $3.62M |
| Pharvaris Bv | 0.36% | $3.62M |
| Amylyx Pharmaceuticals, Inc. | 0.36% | $3.61M |
| Summit Therapeutics, Inc. | 0.34% | $3.41M |
| Viking Therapeutics, Inc. | 0.32% | $3.25M |
| Mirum Pharmaceuticals, Inc. | 0.32% | $3.23M |
| Kestra Medical Technologies, Inc. | 0.32% | $3.19M |
| Biontech SE | 0.31% | $3.11M |
| Damora Therapeutics, Inc. | 0.30% | $3.06M |
| Travere Therapeutics, Inc. | 0.30% | $2.97M |
| Irhythm Technologies, Inc. | 0.29% | $2.95M |
| Dianthus Therapeutics, Inc. | 0.27% | $2.69M |
| Immunocore Holdings PLC | 0.25% | $2.53M |
| Soleno Therapeutics, Inc. | 0.22% | $2.24M |
| Cleerly, Inc. | 0.22% | $2.17M |
| Trevi Therapeutics, Inc. | 0.21% | $2.15M |
| Scholar Rock Holding Corp. | 0.20% | $1.96M |
| Tyra Biosciences, Inc. | 0.19% | $1.92M |
| Biogen, Inc. | 0.18% | $1.83M |
| Revolution Medicines, Inc. | 0.17% | $1.75M |
| Apogee Therapeutics, Inc. | 0.16% | $1.62M |
| Mbx Biosciences, Inc. | 0.15% | $1.49M |
| Medical Microinstruments, Inc. | 0.14% | $1.45M |
| Endeavor Biomedicines, Inc. | 0.14% | $1.36M |
| Kardium Inc/us | 0.13% | $1.32M |
| Upstream Bio, Inc. | 0.13% | $1.30M |
| Insightec Ltd. | 0.13% | $1.26M |
| Iqvia Holdings, Inc. | 0.12% | $1.16M |
| Rallybio Corp. | 0.11% | $1.15M |
| Annexon, Inc. | 0.11% | $1.11M |
| Outset Medical, Inc. | 0.11% | $1.08M |
| Shoulder Innovations, Inc. | 0.11% | $1.07M |
| Contineum Therapeutics, Inc. | 0.10% | $1.04M |
| Parabilis Medicines, Inc. | 0.10% | $1.00M |
| Oruka Therapeutics, Inc. | 0.09% | $858.38K |
| Jade Biosciences, Inc. | 0.08% | $843.00K |
| Element Biosciences, Inc. | 0.08% | $794.68K |
| Zenas Biopharma, Inc. | 0.07% | $746.97K |
| Viphlt Tub Holdings LLC | 0.07% | $744.98K |
| Ocular Therapeutix, Inc. | 0.07% | $708.27K |
| Candid Therapeutics | 0.07% | $687.90K |
| Kardium Inc/us | 0.07% | $674.02K |
| Aledade, Inc. | 0.07% | $670.34K |
| Galvanize Therapeutics | 0.06% | $555.36K |
| Perceptive Capital Solutions Corp. | 0.05% | $548.57K |
| Element Biosciences, Inc. | 0.05% | $540.44K |
| Element Biosciences, Inc. | 0.05% | $540.44K |
| Manus Bio, Inc. | 0.04% | $440.37K |
| Galvanize Therapeutics | 0.04% | $369.01K |
| Wugen, Inc. | 0.04% | $368.49K |
| Asimov, Inc. | 0.03% | $323.96K |
| Aledade, Inc. | 0.03% | $289.34K |
| Kardium Inc/us | 0.03% | $288.40K |
| Saluda Medical, Inc. | 0.03% | $285.18K |
| Immunome, Inc. | 0.02% | $242.76K |
| Shoulder Innovations, Inc. | 0.02% | $233.93K |
| Dmed Biopharmaceutical Co. Ltd. | 0.02% | $234.19K |
| Acumen Pharmaceuticals, Inc. | 0.02% | $225.44K |
| Galvanize Therapeutics | 0.02% | $202.26K |
| Saluda Medical, Inc. | 0.02% | $172.44K |
| Wugen, Inc. | 0.01% | $89.26K |
| Kardium Inc/us | 0.01% | $60.00K |
| Elevatebio, LLC | 0.01% | $57.41K |
| Medical Microinstruments, Inc. | 0.00% | $25.80K |
C000021062 overview: performance, fees, allocation and SEC filings